Charles River Laboratories Reports 2026 Revenue of $982.73M, EPS of $6.86
Revenue fell 2.2% year over year, while net income rose to $333.07 million and diluted EPS increased to $6.86. Management cited improving demand, particularly in Discovery and Safety Assessment.
Charles River Laboratories International reported 2026 results with revenue of $982.73 million, down 2.2% from the prior-year period, while net income rose to $333.07 million and diluted EPS increased to $6.86. Management cited improving demand, particularly in Discovery and Safety Assessment, alon…